Eledon Pharmaceuticals (ELDN) Cash & Equivalents Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Eledon Pharmaceuticals | 419.90 Mn | 203.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 64.58% |
| Dec 31, 2025 | 19.91% |
| Sep 30, 2025 | 56.03% |
| Jun 30, 2025 | -8.11% |
| Mar 31, 2025 | -0.62% |
| Dec 31, 2024 | 18.51% |
| Sep 30, 2024 | -8.99% |
| Jun 30, 2024 | 13.70% |
| Mar 31, 2024 | 25.64% |
| Dec 31, 2023 | -18.68% |
| Sep 30, 2023 | 29.56% |
| Jun 30, 2023 | 30.06% |
| Mar 31, 2023 | -16.03% |
| Dec 31, 2022 | 26.66% |
| Sep 30, 2022 | -13.65% |
| Jun 30, 2022 | -16.44% |
| Mar 31, 2022 | 25.73% |
| Dec 31, 2021 | 137.74% |
| Sep 30, 2021 | 38.24% |
| Jun 30, 2021 | -5.42% |
| Mar 31, 2021 | -8.45% |
| Dec 31, 2020 | -17.47% |
| Sep 30, 2020 | -21.16% |
| Jun 30, 2020 | -31.73% |
| Mar 31, 2020 | -37.80% |
| Dec 31, 2019 | -39.14% |
| Sep 30, 2019 | -36.59% |
| Jun 30, 2019 | -8.31% |
| Mar 31, 2019 | -12.69% |
| Dec 31, 2018 | -16.39% |
| Sep 30, 2018 | -6.72% |